Athira Pharma Inc
ATHA0.386USD
+0.015+4.13%
交易中 （美東）報價延遲15分鐘
USD0.000盤前交易 (美東)
15.05M總市值
虧損本益比TTM
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
營業費用
-65.56%9.54M
-49.20%15.57M
-27.25%25.49M
-11.42%28.03M
-7.00%27.69M
33.65%30.64M
45.20%35.04M
34.24%31.64M
27.29%29.77M
22.10%22.93M
35.38%24.13M
41.67%23.57M
116.93%23.39M
106.83%18.78M
140.99%17.83M
--16.64M
--10.78M
--9.08M
--7.40M
研發費用
-79.74%4.30M
-60.43%9.37M
-34.12%17.92M
2.49%22.15M
-0.27%21.24M
55.42%23.68M
60.34%27.20M
46.02%21.61M
47.25%21.29M
20.75%15.24M
58.45%16.96M
23.11%14.80M
94.22%14.46M
143.26%12.62M
83.65%10.71M
--12.02M
--7.45M
--5.19M
--5.83M
折舊攤銷及損耗
0.41%243.00K
-0.82%243.00K
-0.41%243.00K
-0.82%242.00K
2.54%242.00K
2.51%245.00K
5.63%244.00K
10.41%244.00K
53.25%236.00K
89.68%239.00K
87.80%231.00K
87.29%221.00K
37.50%154.00K
--126.00K
--123.00K
--118.00K
--112.00K
----
----
營業利潤
65.56%-9.54M
49.20%-15.57M
27.25%-25.49M
11.42%-28.03M
7.00%-27.69M
-33.65%-30.64M
-45.20%-35.04M
-34.24%-31.64M
-27.29%-29.77M
-22.10%-22.93M
-35.38%-24.13M
-41.67%-23.57M
-116.93%-23.39M
-106.83%-18.78M
-140.99%-17.83M
---16.64M
---10.78M
---9.08M
---7.40M
淨非營業利息收入（費用）
利息收入
----
----
----
----
----
----
----
----
----
----
1233.78%987.00K
566.22%493.00K
108.33%175.00K
32.91%105.00K
111.43%74.00K
--74.00K
--84.00K
--79.00K
--35.00K
利息費用
----
----
----
----
----
----
----
----
----
----
100.00%2.00K
--0.00
--2.00K
100.00%2.00K
--1.00K
--0.00
--0.00
--1.00K
--0.00
特殊收入（費用）
----
-100.00%0.00
---4.13M
----
----
116.28%1.63M
----
----
----
---10.00M
----
----
----
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---1.09M
其他非經營性收入（費用）
-70.89%393.00K
-67.44%563.00K
-57.53%880.00K
-42.78%1.17M
-30.77%1.35M
-38.07%1.73M
-29.98%2.07M
262.27%2.04M
-12.71%1.95M
19.52%2.79M
42.33%2.96M
-148.63%-1.26M
22.01%2.23M
79.83%2.34M
--2.08M
--2.59M
--1.83M
--1.30M
--0.00
稅前利潤
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
除稅後利潤
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
持續經營利潤
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
歸属于母公司的淨利潤
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
歸屬普通股東的淨利潤
65.28%-9.14M
45.01%-15.00M
12.83%-28.74M
9.25%-26.86M
5.33%-26.34M
9.46%-27.29M
-63.31%-32.97M
-21.62%-29.60M
-32.60%-27.82M
-84.44%-30.14M
-28.81%-20.19M
-74.14%-24.34M
-136.63%-20.98M
-112.14%-16.34M
-85.36%-15.67M
---13.97M
---8.87M
---7.70M
---8.46M
基本每股收益
65.93%-0.23
45.87%-0.39
13.87%-0.75
10.15%-0.70
6.31%-0.69
10.05%-0.72
-62.29%-0.87
-20.56%-0.78
-31.45%-0.73
-118.00%-0.80
-27.08%-0.53
-72.05%-0.65
-125.20%-0.56
-73.93%-0.37
-54.44%-0.42
---0.38
---0.25
---0.21
---0.27
稀釋每股收益
65.93%-0.23
45.87%-0.39
13.87%-0.75
10.15%-0.70
6.31%-0.69
10.05%-0.72
-62.29%-0.87
-20.56%-0.78
-31.45%-0.73
-118.00%-0.80
-27.08%-0.53
-72.05%-0.65
-125.20%-0.56
-73.93%-0.37
-54.44%-0.42
---0.38
---0.25
---0.21
---0.27
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
審計意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
